Skip to main content
ISO 10993-1:2025 global transition guide — Pure Global research report cover on a blue gradient background
Latest
Research Report

ISO 10993-1:2025 Global Transition Guide: How to Build One Biological Evaluation Plan for Seven Regulatory Systems

ISO 10993-1 changed in 2025, but regulators did not change together. This practical guide maps seven regulatory systems and shows how to build one controlled biological-evaluation core with market-specific overlays.

Read full story

All Insights

Filter by:

Items shown: 51

ISO 10993-1:2025 global transition guide — Pure Global research report cover on a blue gradient background
Research Report

ISO 10993-1:2025 Global Transition Guide: How to Build One Biological Evaluation Plan for Seven Regulatory Systems

ISO 10993-1 changed in 2025, but regulators did not change together. This practical guide maps seven regulatory systems and shows how to build one controlled biological-evaluation core with market-specific overlays.

Read full story
IVD Global Market Access 2026 — Pure Global research report cover on a blue gradient background
Research Report

In Vitro Diagnostics Global Market Access 2026: The Year the Rules Moved in Opposite Directions

The EU inverted its IVD regime and the US reverted its own. This report rebuilds what that means for classification, timelines and cost from the registers themselves — including 238 IVDR certificates against 3,343 for devices, and the risk-class split across nine national registers.

Read full story
Orthopedic Implant Global Market Access 2026 — Pure Global research report cover on a blue gradient background
Research Report

Orthopedic Implant Global Market Access 2026: One Implant, Seven Risk Classes — Registration Pathways, Timelines, Fees, and the Two Forces Reshaping Entry

The same orthopedic implant can be Class II in the United States and Class III across the European Union, China, Japan and Australia. This report compares pathways, realistic timelines, government fees, reliance limits and mandatory in-country-representative costs across seven major markets.

Read full story
Aesthetic Device Global Market Access 2026 — Pure Global research report cover on a blue gradient background
Research Report

Aesthetic Device Global Market Access 2026: Registration Pathways, Timelines & Fees for Injectables and Energy-Based Devices

The same aesthetic device can face a different risk class, evidence burden and registration route in every major market. This research report compares fillers and energy-based platforms across the United States, European Union, China, Korea, Brazil and Japan — including realistic timelines, regulator fees, reliance routes and mandatory in-country-representative costs.

Read full story
How to register medical devices and IVDs in Brazil
Blog Article

How to register medical devices and IVDs in Brazil

Registering a medical device or IVD in Brazil means navigating ANVISA's dual pathways—faster Notification for low-risk Class I/II devices, or rigorous Registration for higher-risk Class III/IV devices requiring B-GMP certification and technical dossiers. This guide walks through classification, appointing a Brazil Registration Holder, securing necessary certifications (INMETRO, ANATEL, INCQS), and meeting new UDI labeling requirements. It also covers the AREE reliance pathway, which lets manufacturers with existing FDA, TGA, Health Canada, or MHLW approvals potentially cut review times by 30%.

Read full story
Continuous Glucose Monitors: The Global Map of Regulation, Registration, and Market Access — Pure Global research report
Research Report

Continuous Glucose Monitors: The Global Map of Regulation, Registration, and Market Access

The continuous glucose monitor is the fastest-scaling category in diabetes technology, and in 2024 it broke out of diabetes entirely — onto pharmacy shelves as an over-the-counter wellness product. Yet the same sensor is Class II in the U.S. (now sold OTC), Class IIb in the EU, and Class III in China. This report maps how every major regulator classifies, approves, and reimburses CGM — and why a single FDA clearance or CE mark clears none of the three gates (approval, reimbursement, intellectual property) by itself — with registration costs, timelines, and reliance routes across 30+ markets.

Read full story
AI as a Medical Device: The Global Map of Regulation, Registration, and Market Access — Pure Global research report
Research Report

AI as a Medical Device: The Global Map of Regulation, Registration, and Market Access

Artificial intelligence is the fastest-growing class of medical device in history — and the most regulation-divergent. The U.S. FDA now lists 1,524 AI-enabled devices; South Korea authorized 153 in a single year. Yet the same software is Class II in the U.S., Class IIa+ and 'high-risk' in the EU, and Class III in China — each with its own evidence, local-holder, and change-control rules. This report maps how every major regulator classifies, approves, and polices AI as a medical device, with registration costs, timelines, and reliance routes across 30+ markets, and the playbook for reaching them without rebuilding the dossier each time.

Read full story
How to register medical devices and IVDs in Mexico
Blog Article

How to register medical devices and IVDs in Mexico

Since September 2025, COFEPRIS's new Abbreviated Pathway has opened a faster, more accessible route to market for manufacturers who already hold approvals from major regulatory bodies like the FDA, CE, Health Canada, and others. Instead of navigating a lengthy full technical review, you can now leverage your existing approvals to dramatically cut submission time and complexity. This guide breaks down everything you need to know — from eligibility requirements and device classification to documentation, timelines, and how to appoint a Mexico Registration Holder.

Read full story
How to use your FDA and EU medical device approvals to access 25+ markets
Blog Article

How to use your FDA and EU medical device approvals to access 25+ markets

Your medical device and IVD approvals in the US and EU can streamline pathways in 25+ markets worldwide, from Australia and Switzerland to Brazil and Singapore, cutting the time and cost of international expansion. And with AI-powered tools now helping regulatory specialists build submissions up to 50% faster, scaling your device portfolio across borders has never been more achievable.

Read full story
How to register medical devices and IVDs in Australia
Blog Article

How to register medical devices and IVDs in Australia

Australia is a highly attractive market for medical device manufacturers, but gaining access requires navigating the TGA's rigorous registration process. This step-by-step guide covers the full pathway to ARTG inclusion, from device classification and Sponsor obligations through to Manufacturer Evidence, application submission, and audit preparation, with practical guidance on costs and timelines.

Read full story
ANVISA’s International Cooperation and Regulatory Convergence Are Reshaping Brazil's Medical Device Market
Blog Article

ANVISA’s International Cooperation and Regulatory Convergence Are Reshaping Brazil's Medical Device Market

Brazil's health regulator is moving fast, strengthening international alliances and overhauling key rules for medical devices, software, and post-market surveillance. Learn how ANVISA's 2026–2027 priorities will affect your registration strategy.

Read full story
Christ the Redeemer statue in Rio de Janeiro, Brazil at sunset.
Blog Article

40+ Statistics About Brazil’s Medical Device Import Market Manufacturers Need to Know

Brazil is the largest medical device import market in Latin America, and it's growing faster than it was three years ago. But the countries winning share, the clinical specialties leading growth, and the risks manufacturers need to plan for have all shifted meaningfully since 2021. This article compiles 40+ statistics from Pure Global's four-year import analysis to show what the data actually says.

Read full story
Indonesia's Medical Device and IVD Import Market
Research Report

Indonesia's Medical Device and IVD Import Market

Indonesia's $3.28 Billion MedTech Import Market Reset: The IVD Bubble Is Over; The Surgical Boom Has Begun. The report emphasizes that the 2024 boom was not a simple recovery but a fundamental shift in market demand. The growth was overwhelmingly powered by specialties related to elective and high-acuity procedures, reflecting a move to clear surgical backlogs and a long-term government strategy to improve domestic hospital capabilities.

Read full story
Leveraging Medical Device CE Marking for Faster Entry into Brazil
Blog Article

Leveraging Medical Device CE Marking for Faster Entry into Brazil

Medical device manufacturers sometimes shy away from Brazil as a potential market due to its cumbersome and meticulous regulatory requirements. But if you already have CE Marking, ANVISA approval is more accessible than you think. Learn how ANVISA requirements overlap with the EU MDR.

Read full story
Smart phone calculator on a desk with a laptop and paperwork.
Blog Article

Medical Device Registration Costs and Timelines for Brazil, Mexico, and Colombia

Expanding into Brazil, Mexico, and Colombia can be a major growth driver if you understand the true costs and timelines involved. This guide shows much it costs and how long approvals really take.

Read full story
Thailand's Medical Device and IVD Import Market
Research Report

Thailand's Medical Device and IVD Import Market

Thailand's $3.29 Billion MedTech Import Market Undergoes Radical Shift as Post-Pandemic Demand for Aesthetics and Elder Care Surges, New Research Reveals. An analysis of historical data from 2021 to 2024 reveals an import-driven ecosystem with a total market value fluctuating between approximately $3.15 billion and $3.29 billion annually. This market is fundamentally sustained by two long-term drivers: a rapidly aging population and a thriving medical tourism sector, both of which are amplified by the government's strategic goal to establish the nation as a global "Medical Hub."

Read full story
Brazil's Medical Device and IVD Import Market
Research Report

Brazil's Medical Device and IVD Import Market

Brazil's market for imported medical technology has demonstrated exceptional growth and a significant competitive realignment, establishing itself as a critical destination for global MedTech manufacturers. The total import market surged to USD $9.33 billion in 2024, an impressive 18.0% year-over-year increase, signaling a robust and accelerating demand for advanced healthcare solutions.

Read full story
Mexico city landmark with Mexico flag flying in the wind.
Blog Article

Mexico’s Abbreviated Regulatory Pathway is a Game-Changer for Medical Device Market Access

Mexico’s COFEPRIS will launch its new Abbreviated Regulatory Pathway on September 1, 2025, enabling medical device and drug manufacturers to fast-track approvals by leveraging prior authorizations from trusted international regulators. The streamlined process promises 30-day evaluations, aligning Mexico more closely with global regulatory standards and offering manufacturers a faster route to market.

Read full story
[Research Report] Mexico's Medical Device and IVD Import Market
Research Report

[Research Report] Mexico's Medical Device and IVD Import Market

Mexico's medical device and in-vitro diagnostic (IVD) import market is a dynamic and rapidly expanding landscape, presenting both significant opportunities and complex challenges for global manufacturers. An analysis of historical import data from 2021 to 2024 reveals a market characterized by robust overall growth, shifting competitive dynamics among global trade partners, and transformative regulatory reforms. The total value of medical device and in-vitro diagnostic (IVD) imports to Mexico surged from $6.86 billion in 2021 to $11.40 billion in 2024, marking a 12.6% increase in the final year alone.

Read full story
[Research Report] Malaysia's Medical Device and IVD Market
Research Report

[Research Report] Malaysia's Medical Device and IVD Market

The Malaysian medical device and in-vitro diagnostic (IVD) market presents a compelling, high-growth opportunity, projected to reach US$4.5 billion by 2028 with a robust compound annual growth rate (CAGR) of approximately 9%. This expansion is underpinned by strong economic fundamentals, a consistent increase in government healthcare spending—highlighted by a 10% budget increase for 2025—and a clear national strategy to modernize the healthcare sector.

Read full story
A patient is taking a COVID test with part of the test displayed on a tabletop.
Blog Article

MDCG 2025-5 Clarifies EU Rules for IVD Performance Studies Under IVDR

Dr. Oliver Eikenberg breaks down the European Commission’s new MDCG 2025-5 guidance on IVD performance studies under the IVDR. He highlights how the document clarifies when studies require ethics and authority submissions, what qualifies as a substantial modification, and how to ensure data quality and compliance. For manufacturers and sponsors preparing for CE marking, these insights are essential to avoid costly delays and rejections.

Read full story
Brazil flag waves in the wind
Blog Article

Brazil’s UDI System Nears Enforcement: What Medical Device Manufacturers Must Know for 2025 and Beyond

Brazil’s Unique Device Identification (UDI) system is moving toward full enforcement, with mandatory labeling for Class IV devices starting July 10, 2025. This post breaks down the key requirements under RDC 591/2021 and RDC 884/2024, including SIUD database functions, labeling rules, and preparation steps for manufacturers.

Read full story
[Research Report] ASEAN MedTech Import Market
Research Report

[Research Report] ASEAN MedTech Import Market

Exploring the profound opportunities and increasing complexity in the Association of South-East Asian Nations medical technology import market from 2021-2024. The ASEAN MedTech import market presents significant opportunities amid increasing complexity. Analysis of export data from 2021-2024 reveals robust growth drivers despite top-line volatility. While demographic and economic trends signal sustained demand, aggregate import value fluctuated from $19.16 billion in 2021 to $18.34 billion in 2022, $17.79 billion in 2023, before rebounding to $19.26 billion in 2024.

Read full story
Hands typing on a laptop keyboard
Blog Article

5 Reasons EU device manufacturers should register in EUDAMED today

The European Commission has confirmed that key EUDAMED modules will become mandatory by Q3 2026 and manufacturers selling into the EU need to be ready. This article outlines five key reasons to prioritize EUDAMED registration now to avoid disruption, ensure compliance, and maintain market access.

Read full story
Singapore device registration expedites access to other markets.
Blog Article

Singapore HSA as a Gateway to Faster Device Registration in Key Markets

Singapore’s Health Sciences Authority (HSA) is now a globally recognized reference agency, offering manufacturers a fast track into key Asia-Pacific markets. This article explains how HSA approval can streamline registration in Thailand, Australia, and Hong Kong, and how its WHO Stringent Regulatory Authority status boosts access for high-risk IVDs. Leveraging HSA can cut costs, reduce timelines, and accelerate international expansion.

Read full story
A patient adjusts a medical device smart watch.
Blog Article

Wireless Compliance for Medical Device Manufacturers: Overview of Radio Frequency Module Integration

Manufacturers marketing a wireless medical device must consider communications authority regulations as well as medical device regulations. In this article, Michael Cassidy explains global market access requirements that manufacturers need to consider when integrating wireless module to their device.

Read full story
A globe sits on top of a desk next to a business man working on this laptop.
Blog Article

How the EU IVDR opens doors beyond the EU

Under the IVDR, European CE Marking requires more time and resources from IVD manufacturers than ever before. However, as more countries adopt the EU's approach to medical device and IVD regulation, IVD companies will find themselves well positioned to access other markets beyond the EU once their IVDR CE Mark is in place. In this article, Dr. Oliver Eikenberg discusses the potential to leverage IVDR CE Marking to streamline global market access.

Read full story
Supply chain controls for Economic Operators under the EU IVDR
Blog Article

Supply chain requirements for Economic Operators under the EU IVDR

Inadequate supply chain controls are a leading cause of non-conformities in Notified Body Technical Documentation Assessments under the IVDR. In this article, Dr. Oliver Eikenberg discusses how manufacturers should assess and update their supply chain agreements to ensure Economic Operator roles and obligations are clearly defined in line with IVDR requirements.

Read full story
Clinical Evidence under IVDR: what is an “adequate level” for IVD manufacturers?
Blog Article

Clinical Evidence under IVDR: what is an “adequate level” for IVD manufacturers?

Conformity under the IVDR requires a rigorous approach to clinical evidence quality. In this article, Dr. Oliver Eikenberg explains the importance of performance evaluation processes and documentation to ensure adequate clinical evidence for EU IVDR compliance.

Read full story
RIVM report: The impact of the new European IVD-classification rules on notified body involvement A study on IVDs registered in the Netherlands
Blog Article

Engaging a Notified Body under the IVDR: What legacy manufacturers need to know about the pre-application process

The IVDR transition includes structured processes IVD manufacturers must follow to engage with Notified Bodies. Many IVD manufacturers are interacting with Notified Bodies for the first time and must understand what is required to ensure a successful partnership. In this article, Dr. Oliver Eikenberg clarifies what manufacturers must prepare and when to engage a Notified Body for IVDR CE Marking.

Read full story
Regulatory requirements and challenges for new and old Class D devices under IVDR
Blog Article

Regulatory requirements and challenges for new and old Class D devices under IVDR

Class D IVD manufacturers face fast-approaching IVDR transition deadlines, though some are more familiar with the regulatory process. In this article, Dr. Oliver Eikenberg discusses the difference between "new" and "old" Class Ds, and regulatory logistics they need to consider during the transition process.

Read full story
Intended purpose for IVDs and impact on the classification under IVDR
Blog Article

Intended purpose for IVDs and impact on the classification under IVDR

Your IVD's intended purpose determines its classification, clinical evidence requirements, and clinical applications under the IVDR. Device companies will need a more robust intended purpose to fulfill IVDR criteria. In this article, Dr. Oliver Eikenberg explains the role of the intended purpose in IVDR compliance.

Read full story
Why and How EU IVDR Compliance Matters before the May 2025 Deadline
Blog Article

Why and How EU IVDR Compliance Matters before the May 2025 Deadline

Many IVD and legacy IVD device manufacturers are obligated to comply with certain aspects of the IVDR even before their transition deadline. In this article, Oliver Eikenberg discusses how IVD companies can maintain EU compliance during the transition period.

Read full story
Adapting your QMS to IVDR requirements until May 2025: what manufacturers need to know
Blog Article

Adapting your QMS to IVDR requirements until May 2025: what manufacturers need to know

The official IVDR transition period is here. IVDR expert Dr. Oliver Eikenberg discusses how IVD manufacturers should take action, starting with how to implement IVDR QMS requirements for the May 2025 deadline.

Read full story
Kuala Lumpur Malaysia Skyline
Blog Article

MDA Updates at IMDEC 2024: Paving the Way for Regulatory Excellence and Innovation in Medical Technology

Pure Global participated in IMDEC 2024 in Kuala Lumpur to discuss the latest advancements in medical technology, regulatory efficiency, and the role of AI in transforming the industry. Highlights included updates from the Malaysian Medical Device Authority (MDA) that showcased their commitment to driving regional leadership in medical device regulation and innovation.

Read full story
Pure Global 2024 Year in Review
Blog Article

Pure Global 2024: A Year of Growth, Innovation, and Global Impact

As 2024 comes to a close, Pure Global proudly reflects on a transformative year marked by substantial growth, cutting-edge innovation, and impactful collaborations.

Read full story
Risk increases compliance chalenges under IVDR
Blog Article

What are the challenges under IVDR?

IVD manufacturers cite the new classification system, detailed definitions for intended purposes, and the need for verification of clinical evidence as key challenges under the IVDR.

Read full story
The EU Parliament votes on a resolution to revise specific parts of the MDR and IVDR
Blog Article

The EU Parliament votes on a resolution to revise specific parts of the MDR and IVDR

On October 23, the European Parliament adopted a resolution revising specific elements of the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Devices Regulation (IVDR). This resolution intends to address ongoing challenges in implementing the regulations by 2025 and to improve patient access to important medical products.

Read full story
Transla.ai: Simplifying Multi-Language Documentation for Global MedTech Companies
Blog Article

Transla.ai: Simplifying Multi-Language Documentation for Global MedTech Companies

Multilingual documentation presents ongoing compliance and logistical hurdles for MedTech manufacturers. Transla.Ai is an industry-specific translation tool that can accelerate and streamline the translation process.

Read full story
Changing Global Markets - Brazil: Navigating New Regulatory Landscapes
Blog Article

Changing Global Markets - Brazil: Navigating New Regulatory Landscapes

Brazil aligns medical device regulations with global standards, including Europe and the US. Recent updates and international compatibility attract manufacturers.

Read full story
The Impact of AI on Brazil's MedTech Sector
Blog Article

The Impact of AI on Brazil's MedTech Sector

AI is revolutionizing MedTech in Brazil, enhancing healthcare through process optimization and data-driven decisions. Pure Global ensures swift, compliant market introduction of innovative solutions.

Read full story
Pure Global: Regulatory Decisions for Global Success
Blog Article

Pure Global: Regulatory Decisions for Global Success

Discover how to navigate commercial and regulatory challenges for global success in the medical device industry. Learn strategies for market access, regulatory compliance, and post-market vigilance

Read full story
New Standards in Med Dev Cybersecurity
Blog Article

New Standards in Med Dev Cybersecurity

Raising cybersecurity standards for medical devices necessitates manufacturers' compliance with new global regulations.

Read full story
Brazilian Markets Navigation: Pure Global Alliance
Blog Article

Brazilian Markets Navigation: Pure Global Alliance

Brazil stands as Latin America's largest medical device market, regulated by ANVISA with recent updates to accommodate new technologies and international harmonization.

Read full story
US Regulatory insights: Global Collaboration
Blog Article

US Regulatory insights: Global Collaboration

Combining expert regulatory guidance with cutting-edge clinical laboratory support to streamline the FDA approval process.

Read full story
Partnering with Pure Global Singapore
Blog Article

Partnering with Pure Global Singapore

With a population of 5+ million, Singapore has the highest GDP per capita in Asia, according to Trading Economics.

Read full story
Decoding Health tech Regulations
Blog Article

Decoding Health tech Regulations

Exploring the evolution from wellness apps to regulated medical devices, highlighting the significance of global compliance and security.

Read full story
Outsourced vs DIY Regulatory services: Perspectives
Blog Article

Outsourced vs DIY Regulatory services: Perspectives

Addressing product development and regulatory hurdles, medical device and IVD manufacturers are advised to assess capabilities and seek external expertise for market success.

Read full story
Human Factors in Med Device Manufacturing
Blog Article

Human Factors in Med Device Manufacturing

An overview of essential human factors engineering standards and guidance for global medical device manufacturers.

Read full story
Recall Management: Med dev Post-Market Duties
Blog Article

Recall Management: Med dev Post-Market Duties

Navigating the complexities of medical device recalls requires a robust management plan and clear communication strategies.

Read full story
Unlocking Device Market Access: Reimbursement Essentials
Blog Article

Unlocking Device Market Access: Reimbursement Essentials

A guide to regulatory clearances, global reimbursement strategies, and the essential PICO approach.

Read full story

essential industry news delivered to your inbox

Thank you for subscribing!
Oops! Something went wrong while submitting the form.
By subscribing, you agree to our Terms of Use.

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Contact us